2-(2,6-DIFLUOROPHENYL)-N-METHOXY-N-METHYLACETAMIDE, 95.0%, 250mg

5-Amino-2-fluorobenzotrifluoride, 99.0%, 500g

1-Butyl-6-hydroxy-4-methyl-2-oxo-1,2-dihydropyridine-3-carbonitrile, 97%, 5g

sodium 3-acetyl-6-methyl-2-oxo-2H-pyran-4-olate, 98%, 100g

(1R)-((2S,4S,5R)-5-Ethylquinuclidin-2-yl)(6-methoxyquinolin-4-yl)methanol, 95.0%, 250mg

Rociletinib, 99%, 50mg

Dichlorobis(dicyclohexylphenylphosphine)nickel(II)>95.0%(T)250mg

2-Vinylpyridine (stabilised with tert-Butylcatechol), 95.0%, 1g

1,4-Epoxy-1,4-dihydronaphthalene, 95.0%, 25g

Proteinasi K, 1 g

2,4-Diiodoaniline, 97.0%, 5g

(6E)-8-METHYL-6-NONENOIC ACID (4-HYDROXY-3-METHOXYPHENYL)METHYL ESTER, 95%, 5mg

1,2-Bis(2-methyl-5-(pyridin-4-yl)thiophen-3-yl)cyclopent-1-ene, 95%, 100mg